NCT07274033 Effect of Manual Lymphatic Drainage on Muscle Fatigue in Female 11-a-side Football Players
| NCT ID | NCT07274033 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Camilo Jose Cela University |
| Condition | Women |
| Study Type | INTERVENTIONAL |
| Enrollment | 11 participants |
| Start Date | 2025-11-17 |
| Primary Completion | 2026-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 11 participants in total. It began in 2025-11-17 with a primary completion date of 2026-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial investigates the effectiveness of manual lymphatic drainage (MLD) in accelerating recovery following induced fatigue in female football players. The study integrates objective performance measurements using linear encoders with anthropometric assessments and psychophysiological evaluations. It aims to quantify the impact of MLD on neuromuscular recovery, muscle edema, and perceived fatigue, considering sex-specific physiological factors and the influence of sleep and psychological stress. The findings will contribute to developing non-invasive, individualized recovery strategies to enhance performance and reduce injury risk in women's football.
Eligibility Criteria
Inclusion Criteria: * Female athletes actively participating in 11-a-side football, either federated or official team members. * Age ≥ 16 years to 20 years old. * Regular training (≥ 3 sessions per week) or active competition * No food intake within 3 hours prior to evaluation (to standardize the influence of digestion on performance). * No acute lower limb injury in the past 3 months. * Availability to attend all three study visits. * Signed informed consent; for participants under 18, parental consent is also required. Exclusion Criteria: * History of deep vein thrombosis * Decompensated heart failure * Active lower limb infection * Pregnancy * Recent lower limb surgery (\< 3 months), or any medical contraindication to receiving manual lymphatic drainage (MLD). * Failure to comply with the fasting requirement prior to performance testing.
Contact & Investigator
Edurne Úbeda Docasar, Doctor
PRINCIPAL INVESTIGATOR
University Camilo José Cela
Frequently Asked Questions
Who can join the NCT07274033 clinical trial?
This trial is open to female participants only, aged 16 Years or older, up to 20 Years, studying Women. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07274033 currently recruiting?
Yes, NCT07274033 is actively recruiting participants. Contact the research team at eubeda@ucjc.edu for enrollment information.
Where is the NCT07274033 trial being conducted?
This trial is being conducted at Madrid, Spain.
Who is sponsoring the NCT07274033 clinical trial?
NCT07274033 is sponsored by Camilo Jose Cela University. The principal investigator is Edurne Úbeda Docasar, Doctor at University Camilo José Cela. The trial plans to enroll 11 participants.